DiaMedica Therapeutics Inc. (DMAC) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts DMAC Hot Sheet
Join SI Premium – FREE
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) reported Q3 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).
For earnings history and earnings-related data on DiaMedica Therapeutics Inc. (DMAC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Latham Group, Inc. (SWIM) Misses Q3 EPS by 5c ; Offers Guidance
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Varonis Systems (VRNS) Tops Q3 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
